| Ligand-binding domain of an α7-nicotinic receptor chimera and its complex with agonist SX Li, S Huang, N Bren, K Noridomi, CD Dellisanti, SM Sine, L Chen Nature neuroscience 14 (10), 1253-1259, 2011 | 221 | 2011 |
| Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2 N Jayathilaka, A Han, KJ Gaffney, R Dey, JA Jarusiewicz, K Noridomi, ... Nucleic acids research 40 (12), 5378-5388, 2012 | 74 | 2012 |
| Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications K Noridomi, G Watanabe, MN Hansen, GW Han, L Chen Elife 6, e23043, 2017 | 26 | 2017 |
| α1-FANGs: protein ligands selective for the α-bungarotoxin site of the α1-nicotinic acetylcholine receptor AL Nichols, K Noridomi, CR Hughes, F Jalali-Yazdi, JB Eaton, LH Lai, ... ACS chemical biology 13 (9), 2568-2576, 2018 | 8 | 2018 |
| Structure-Based Approaches to Antigen-Specific Therapy of Myasthenia Gravis J Xu, K Noridomi, L Chen Selected Topics in Myasthenia Gravis, 2019 | | 2019 |
| Structural studies of nicotinic acetylcholine receptor α1 subunit and Fab35 complex to understand autoimmune disease of myasthenia gravis K Noridomi, G Watanabe, M Hansen, L Chen Biochemical Pharmacology 4 (97), 627, 2015 | | 2015 |
| Ligand-binding domain of an [alpha subscript 7]-nicotinic receptor chimera and its complex with agonist SX Li, S Huang, N Bren, K Noridomi, CD Dellisanti, SM Sine, L Chen Nat. Neurosci. 14 (2011), 2013 | | 2013 |
| Inhibition of the Interaction between class IIa HDAC and MEF2 by Small Molecules N Jayathilaka, A Han, KJ Gaffney, R Dey, JA Jarusiewicz, K Noridomi, ... | | |
